# Interferon Treatment for Patients With Chronic Hepatitis C and End Stage Renal Disease

> **NCT00172809** · PHASE4 · COMPLETED · sponsor: **National Taiwan University Hospital** · enrollment: 50 (actual)

## Conditions studied

- Chronic Hepatitis C
- End Stage Renal Disease

## Interventions

- **DRUG:** Peginterferon alfa-2a
- **DRUG:** Interferon alfa-2a

## Key facts

- **NCT ID:** NCT00172809
- **Lead sponsor:** National Taiwan University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-07
- **Primary completion:** 2006-06
- **Final completion:** 2007-01
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2008-03-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00172809

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00172809, "Interferon Treatment for Patients With Chronic Hepatitis C and End Stage Renal Disease". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00172809. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*